- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CG Invites Co Ltd (083790)
CG Invites Co Ltd stock price live, this page displays KQ 083790 stock exchange data. View the 083790 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the CG Invites Co Ltd real time stock price chart below.
What Is the CG Invites Co Ltd Stock Price Today?
The CG Invites Co Ltd stock price today is 762.
What Is the Stock Symbol for CG Invites Co Ltd?
The stock symbol for CG Invites Co Ltd is "083790."
What Stock Exchange Does CG Invites Co Ltd Trade On?
CG Invites Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is CG Invites Co Ltd a Good Stock to Buy?
Determining whether CG Invites Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 083790 quote. (ISIN: KR7083790006)
What Is the CG Invites Co Ltd Stock Price Today?
The CG Invites Co Ltd stock price today is 762.
What Is the Stock Symbol for CG Invites Co Ltd?
The stock symbol for CG Invites Co Ltd is "083790."
What Stock Exchange Does CG Invites Co Ltd Trade On?
CG Invites Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is CG Invites Co Ltd a Good Stock to Buy?
Determining whether CG Invites Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 083790 quote. (ISIN: KR7083790006)
KOSDAQ
Currency in KRW
762
+18(+2.42%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
745
772
52 wk Range
711
1,985
083790 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
745772
52 wk Range
7111,985
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
083790 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low Price / Book multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Earnings
Latest Release
May 14, 2026
EPS / Forecast
-58.10 / --
Revenue / Forecast
4.29B / --
Compare 083790 to Peers and Sector
Metrics to compare | 083790 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship083790PeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.9x | −6.7x | −0.3x | |
PEG Ratio | −0.15 | −0.16 | 0.00 | |
Price/Book | 0.6x | 1.2x | 2.6x | |
Price / LTM Sales | 2.0x | 7.2x | 3.0x | |
Upside (Analyst Target) | - | 31.9% | 56.6% | |
Fair Value Upside | Unlock | 20.6% | 10.2% | Unlock |
CG Invites Co., Ltd., a biopharma company, engages in the discovery and development of structural chemoproteiomics-based drugs in Korea. It offers Acelex (polmacoxib), an anti-inflammatory and pain relief drug, as well as CG-650, an anti-inflammatory drug, currently under phase 1 stage for the treatment of osteoarthritis; CG-651, an anti-inflammatory drug, currently under phase 1 stage for the treatment of neuropathic pain; and CG-652, an anti-inflammatory drug, currently under phase 1 stage for the treatment of rheumatoid arthritis. The company is also involved in the development of Ivaltinostat, an anti-cancer drug, currently under phase 2 stage for the treatment of pancreatic cancer and myelodysplastic syndrome, as well as preclinical stage for the treatment of acute myeloid leukemia and hepatocellular carcinoma; Camrelizumab, an anti-cancer drug, currently under phase 3 stage for the treatment of NSCLC; and Luxeptinib, an anti-cancer drug, currently under phase 1 stage for the treatment of acute myeloid leukemia, chronic lymphocytic leukemia, and non-hodgkin’s lymphoma. In addition, it engages in the development of Nilofabicin, anti-infective drug, currently under phas 1 stage for the treatment of MRSA infection; and Ivaltinostat, currently under phase 1 stage for the treatment of fibrotic and metabolic diseases, such as fibrosis. The company was formerly known as CrystalGenomics Invites Co., LTD. and changed its name to CG Invites Co., Ltd. in April 2024. CG Invites Co., Ltd. was incorporated in 2000 and is headquartered in Seoul, South Korea.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the CG Invites (083790) Stock Price Today?
The CG Invites stock price today is 762 KRW.
What Stock Exchange Does CG Invites Trade On?
CG Invites is listed and trades on the KOSDAQ.
What Is the Stock Symbol for CG Invites?
The stock symbol for CG Invites is "083790."
What Is the CG Invites Market Cap?
As of today, CG Invites market cap is 58.59B KRW.
What Is CG Invites's Earnings Per Share (TTM)?
The CG Invites EPS (TTM) is -55.
From a Technical Analysis Perspective, Is 083790 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has CG Invites Stock Split?
CG Invites has split 7 times.
How Many Employees Does CG Invites Have?
CG Invites has 73 employees.
What is the current trading status of CG Invites (083790)?
As of Jul 31, 2026, CG Invites (083790) is trading at a price of 762 KRW, with a previous close of 744 KRW. The stock has fluctuated within a day range of 745 KRW to 772 KRW, while its 52-week range spans from 711 KRW to 1,985 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.